Versatile pathway-centric approach based on high-throughput sequencing to anticancer drug discovery.
about
Integrated analysis of drug-induced gene expression profiles predicts novel hERG inhibitorsChemical approaches to stem cell biology and therapeuticsPathoQC: Computationally Efficient Read Preprocessing and Quality Control for High-Throughput Sequencing Data Sets.Reprogramming cell fates by small molecules.Chem-seq permits identification of genomic targets of drugs against androgen receptor regulation selected by functional phenotypic screens.Sensitive, multiplex and direct quantification of RNA sequences using a modified RASL assay.RASL-seq for massively parallel and quantitative analysis of gene expression.Pathway reporter genes define molecular phenotypes of human cellsConcise review: chemical approaches for modulating lineage-specific stem cells and progenitors.Network based elucidation of drug response: from modulators to targets.Assessing the impact of human genome annotation choice on RNA-seq expression estimates.A trichostatin A expression signature identified by TempO-Seq targeted whole transcriptome profilingBufalin is a potent small-molecule inhibitor of the steroid receptor coactivators SRC-3 and SRC-1Modeling psychiatric disorders with patient-derived iPSCs.Peruvoside, a Cardiac Glycoside, Induces Primitive Myeloid Leukemia Cell Death.A novel hanging spherical drop system for the generation of cellular spheroids and high throughput combinatorial drug screening.Src mediates extracellular signal-regulated kinase 1/2 activation and autophagic cell death induced by cardiac glycosides in human non-small cell lung cancer cell lines.Micro-scaffold array chip for upgrading cell-based high-throughput drug testing to 3D using benchtop equipment.Targeted transcript profiling by sequencing.Investigation of the antimicrobial activity of soy peptides by developing a high throughput drug screening assay.Identification of Triptophenolide from Tripterygium wilfordii as a Pan-antagonist of Androgen Receptor.
P2860
Q28534789-3D4808AF-3C3E-4EBB-93E4-26E054FFCCCCQ30431314-392A1762-077A-45CF-924A-4A36F73410A5Q30953170-C7C67A7E-5BC8-4E43-82E7-D8AA0D7CD28AQ33628088-6CBA719B-0F06-4F04-9207-09B9CE7090A9Q33835065-D8904850-0A48-45CA-8387-3C0A6134D7B6Q34044453-878F0B10-06F3-4DCA-9B29-D071C5885016Q34217185-3DF90A8B-1B78-436B-9F7F-50970784B809Q34473230-0118B591-11E1-408C-9DD7-78A851881F7FQ34666395-DE75F6CA-2D6F-4155-9604-0CF39A54687BQ35065347-4F669093-9688-4B7B-A6F6-58DF87B5B8A2Q35101492-08E97247-0AFA-41DD-9206-7FC369CA88DFQ36380832-A9FE53A2-79E7-401A-8D73-019CF8CE3468Q37626561-F8273544-027E-48A5-A57F-4100D61EDDC8Q38679839-9D11E01B-0F11-4F47-93C5-F97698A66B27Q38775646-03C7A54D-31B9-4594-B860-2D0BD8E805D1Q38848195-412A126F-3649-4F20-AD5D-5FC28DA3AED9Q39017201-C9F2E80A-B29E-48B6-8AA5-0226C72E73E4Q39052415-7FB41D19-C8FD-40B2-8CA4-25406F1E6BD3Q41355225-8D11BC1E-239B-4E10-9644-D5B09683F339Q41683093-F728702E-6A76-40B7-9FDC-6D1CD7D7CE1BQ54296578-15C6AEC6-7697-4404-ADE1-2DCF1F958349
P2860
Versatile pathway-centric approach based on high-throughput sequencing to anticancer drug discovery.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Versatile pathway-centric appr ...... to anticancer drug discovery.
@ast
Versatile pathway-centric appr ...... to anticancer drug discovery.
@en
type
label
Versatile pathway-centric appr ...... to anticancer drug discovery.
@ast
Versatile pathway-centric appr ...... to anticancer drug discovery.
@en
prefLabel
Versatile pathway-centric appr ...... to anticancer drug discovery.
@ast
Versatile pathway-centric appr ...... to anticancer drug discovery.
@en
P2093
P2860
P356
P1476
Versatile pathway-centric appr ...... to anticancer drug discovery.
@en
P2093
Hongyan Zhou
Jinsong Qiu
Michael G Rosenfeld
Sheng Ding
Xiang-Dong Fu
Xiangqiang Li
P2860
P304
P356
10.1073/PNAS.1200305109
P407
P577
2012-03-06T00:00:00Z